- Home
- CDNA vs FMBH Comparison
CDNA vs FMBH Comparison
Compare CDNA & FMBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- FMBH
- Stock Information
- Founded
- CDNA 1998
- FMBH 1865
- Country
- CDNA United States
- FMBH United States
- Employees
- CDNA N/A
- FMBH N/A
- Industry
- CDNA Medical Specialities
- FMBH Major Banks
- Sector
- CDNA Health Care
- FMBH Finance
- Exchange
- CDNA Nasdaq
- FMBH Nasdaq
- Market Cap
- CDNA 712.2M
- FMBH 853.8M
- IPO Year
- CDNA 2014
- FMBH N/A
- Fundamental
- Price
- CDNA $11.84
- FMBH $37.57
- Analyst Decision
- CDNA Buy
- FMBH Hold
- Analyst Count
- CDNA 6
- FMBH 5
- Target Price
- CDNA $27.67
- FMBH $43.40
- AVG Volume (30 Days)
- CDNA 1.5M
- FMBH 67.9K
- Earning Date
- CDNA 08-06-2025
- FMBH 07-24-2025
- Dividend Yield
- CDNA N/A
- FMBH 2.66%
- EPS Growth
- CDNA N/A
- FMBH 13.11
- EPS
- CDNA 1.00
- FMBH 3.52
- Revenue
- CDNA $340,826,000.00
- FMBH $328,480,000.00
- Revenue This Year
- CDNA $12.81
- FMBH N/A
- Revenue Next Year
- CDNA $13.36
- FMBH $4.60
- P/E Ratio
- CDNA $11.87
- FMBH $10.67
- Revenue Growth
- CDNA 14.72
- FMBH 7.81
- 52 Week Low
- CDNA $10.96
- FMBH $27.58
- 52 Week High
- CDNA $34.84
- FMBH $43.86
- Technical
- Relative Strength Index (RSI)
- CDNA 33.98
- FMBH 45.18
- Support Level
- CDNA $11.73
- FMBH $37.08
- Resistance Level
- CDNA $12.76
- FMBH $39.42
- Average True Range (ATR)
- CDNA 0.64
- FMBH 0.95
- MACD
- CDNA 0.13
- FMBH -0.02
- Stochastic Oscillator
- CDNA 28.61
- FMBH 28.24
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.